uFlowAM: an unsupervised framework for detection and visualization of abnormal intracardiac microflow on early-pregnancy fetal cardiac microflow imaging - Scorecard - MDSpire

uFlowAM: an unsupervised framework for detection and visualization of abnormal intracardiac microflow on early-pregnancy fetal cardiac microflow imaging

  • By

  • Yan Xia

  • Yarui Wei

  • Zhanru Lan

  • Ning Wu

  • Yongxin Li

  • Xueqin Ji

  • July 9, 2026

  • 0 min

Share

Clinical Scorecard: uFlowAM: A Novel Unsupervised Approach for Identifying and Visualizing Abnormal Intracardiac Microflow in Early-Pregnancy Fetal Cardiac Microflow Imaging

At a Glance

CategoryDetail
ConditionCongenital Heart Disease (CHD)
Key MechanismsDetection and visualization of abnormal intracardiac microflow patterns using unsupervised learning.
Target PopulationPregnant individuals with early-pregnancy fetuses at risk for CHD.
Care SettingMulticenter diagnostic accuracy study for fetal cardiac assessment.

Key Highlights

  • uFlowAM achieved an AUC of 0.94 in the internal cohort and 0.92 in the external cohort.
  • Sensitivity of 0.92 and specificity of 0.88 in the internal cohort.
  • Median reading time decreased from 78 seconds to 59 seconds with uFlowAM assistance.
  • Weighted kappa for subtype agreement increased from 0.62 to 0.78.
  • Visibility scores improved from 2.8 ± 0.6 to 4.3 ± 0.5.

Guideline-Based Recommendations

Diagnosis

  • Use uFlowAM as an assistive tool for detecting abnormal fetal cardiac microflow patterns.

Management

  • Do not use uFlowAM as a substitute for a complete fetal echocardiographic examination.

Monitoring & Follow-up

  • Monitor fetal cardiac microflow patterns in early pregnancy for potential CHD.

Risks

  • Consider the limitations of image quality and fetal position affecting detection accuracy.

Patient & Prescribing Data

Pregnant individuals undergoing fetal cardiac microflow imaging due to suspected CHD.

uFlowAM enhances detection of microflow abnormalities, potentially influencing follow-up and referral decisions.

Clinical Best Practices

  • Incorporate uFlowAM in early-pregnancy FCMI assessments to improve detection rates.
  • Ensure comprehensive fetal echocardiographic evaluations are performed alongside uFlowAM findings.

Related Resources & Content

    Original Source(s)

    Related Content